Free Trial

Elevation Oncology (ELEV) Institutional Ownership

Elevation Oncology logo
$0.71 +0.04 (+6.24%)
As of 01/17/2025 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Elevation Oncology (NASDAQ:ELEV)

Current
Institutional Ownership
Percentage
83.70%
Number of
Institutional Buyers
(last 12 months)
18
Total
Institutional Inflows
(last 12 months)
$67.83M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$14.29M
Get ELEV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Elevation Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELEV Institutional Buying and Selling by Quarter

Elevation Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/17/2025 SG Americas Securities LLC61,467$35K0.0%+33.9%0.104%
12/26/2024JPMorgan Chase & Co.61,334$37K0.0%+175.9%0.104%
11/19/2024Barclays PLC72,077$43K0.0%+302.4%0.122%
11/16/2024Geode Capital Management LLC1,110,085$666K0.0%+7.6%1.878%
11/15/2024Frazier Life Sciences Management L.P.5,993,579$3.60M0.1%+102.6%10.138%
11/15/2024Barclays PLC72,077$43K0.0%+302.4%0.122%
11/15/2024Sphera Funds Management LTD.1,079,762$648K0.1%+227.2%1.826%
11/15/2024State Street Corp1,018,026$611K0.0%+13.5%1.722%
11/14/2024Braidwell LP473,503$284K0.0%-80.9%0.801%
11/5/2024GSA Capital Partners LLP433,545$260K0.0%N/A0.733%
10/3/2024 SG Americas Securities LLC45,907$28K0.0%N/A0.084%
8/19/2024Point72 Asset Management L.P.1,680,230$4.54M0.0%-50.1%3.075%
8/16/2024Frazier Life Sciences Management L.P.2,958,579$7.99M0.4%N/A5.415%
8/15/2024Darwin Global Management Ltd.1,916,290$4.81M0.6%-17.9%3.507%
8/15/2024Affinity Asset Advisors LLC1,468,825$3.97M0.5%+15.8%2.688%
8/14/2024Marshall Wace LLP37,738$102K0.0%-71.6%0.069%
8/14/2024Logos Global Management LP3,850,000$10.40M0.8%+285.0%7.046%
8/14/2024Farallon Capital Management LLC3,598,418$9.72M0.0%-7.4%6.586%
8/12/2024XTX Topco Ltd38,179$103K0.0%N/A0.070%
8/8/2024American Century Companies Inc.49,222$133K0.0%+55.7%0.090%
8/1/2024Rhumbline Advisers64,910$175K0.0%N/A0.119%
7/26/2024Bank of New York Mellon Corp153,586$415K0.0%N/A0.281%
5/24/2024Farallon Capital Management LLC3,886,663$19.94M0.1%N/A7.113%
5/17/2024Artal Group S.A.1,513,015$7.76M0.2%N/A2.769%
5/17/2024Ikarian Capital LLC148,089$760K0.1%-87.4%0.271%
5/15/2024venBio Partners LLC2,696,133$13.83M4.9%-7.5%4.934%
5/15/2024Darwin Global Management Ltd.2,332,928$11.97M1.6%N/A4.270%
5/15/2024Affinity Asset Advisors LLC1,268,825$6.51M0.8%N/A2.322%
5/10/2024Vanguard Group Inc.1,532,045$7.86M0.0%+30.8%2.804%
5/7/2024 SG Americas Securities LLC12,244$63K0.0%N/A0.022%
11/15/2023Armistice Capital LLC750,000$497K0.0%-68.7%1.768%
8/15/2023Sphera Funds Management LTD.900,000$1.37M0.2%N/A2.124%
8/15/2023Caxton Corp21,725$33K0.1%-68.2%0.051%
8/11/2023Velan Capital Investment Management LP497,299$756K0.7%N/A1.173%
8/11/2023ExodusPoint Capital Management LP1,499,319$2.28M0.0%N/A6.160%
5/15/2023Sio Capital Management LLC876,611$1.67M0.8%+143.7%3.685%
5/1/2023Virtu Financial LLC27,286$52K0.0%N/A0.115%
2/15/2023Tang Capital Management LLC479,854$456K0.1%N/A2.059%
2/13/2023BML Capital Management LLC39,963$38K0.0%N/A0.172%
11/14/2022Annandale Capital LLC30,000$34K0.0%N/A0.129%
Do this Before Elon’s Reveal on January 22nd (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.
11/14/2022Cormorant Asset Management LP1,952,032$2.21M0.2%-1.6%8.377%
8/16/2022venBio Partners LLC1,866,339$2.61M0.7%-28.4%8.013%
8/10/2022Kennedy Capital Management Inc.149,893$210K0.0%+968.4%0.644%
4/26/2022 Marquette Asset Management LLC38,951$98K0.0%+332.5%0.168%
4/25/2022Bailard Inc.23,500$59K0.0%N/A0.101%
2/18/2022TCG Crossover Management LLC555,000$3.34M1.6%N/A2.389%
2/15/2022Kennedy Capital Management Inc.15,485$93K0.0%N/A0.067%
2/14/2022Boxer Capital LLC872,780$5.25M0.2%-34.9%3.758%
2/14/2022Sio Capital Management LLC250,000$1.51M0.5%N/A1.076%
1/19/2022 Marquette Asset Management LLC9,006$54K0.0%N/A0.039%
11/16/2021Schonfeld Strategic Advisors LLC18,044$141K0.0%-29.8%0.078%
11/16/2021Janus Henderson Group PLC1,220,205$9.38M0.0%+18.3%5.254%
11/16/2021Caxton Corp48,183$375K0.3%+21.7%0.207%
11/9/2021BlackRock Inc.23,837$186K0.0%N/A0.103%
8/17/2021Weiss Multi Strategy Advisers LLC15,037$204K0.0%N/A0.066%
8/17/2021Woodline Partners LP112,431$1.53M0.0%N/A0.493%
8/17/2021Samsara BioCapital LLC932,239$12.65M1.6%N/A4.085%
8/17/2021Sphera Funds Management LTD.30,000$407K0.0%N/A0.131%
8/17/2021Millennium Management LLC123,062$1.67M0.0%N/A0.539%
8/17/2021BVF Inc. IL1,590,291$21.58M0.8%N/A6.968%
8/17/2021Boxer Capital LLC1,341,530$18.21M0.6%N/A5.878%
8/17/2021Caas Capital Management LP60,000$814K0.0%N/A0.263%
8/17/2021Caxton Corp39,586$537K0.4%N/A0.173%
8/16/2021LMR Partners LLP31,300$425K0.0%N/A0.137%
8/16/2021Point72 Asset Management L.P.50,000$679K0.0%N/A0.219%
8/16/2021venBio Partners LLC2,608,167$35.39M4.2%N/A11.428%
8/16/2021Alyeska Investment Group L.P.125,000$1.70M0.0%N/A0.548%
8/16/2021Schonfeld Strategic Advisors LLC25,700$349K0.0%N/A0.113%
8/16/2021Pinz Capital Management LP36,400$494K0.1%N/A0.159%
8/16/2021Maven Securities LTD16,000$204K0.0%N/A0.070%
8/16/2021Goldman Sachs Group Inc.62,500$848K0.0%N/A0.274%
8/13/2021Northern Trust Corp4,803$65K0.0%N/A0.021%
8/13/2021Qube Research & Technologies Ltd24,255$329K0.0%N/A0.106%
8/13/2021Vanguard Group Inc.60,000$814K0.0%N/A0.263%
8/12/2021Monashee Investment Management LLC140,000$1.90M0.2%N/A0.613%
8/11/2021Ghost Tree Capital LLC100,000$1.36M0.4%N/A0.438%
(Data available from 1/1/2016 forward)

ELEV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELEV shares?

During the previous two years, 31 institutional investors and hedge funds held shares of Elevation Oncology. The most heavily invested institutionals were venBio Partners LLC ($13.83M), Logos Global Management LP ($10.40M), Farallon Capital Management LLC ($9.72M), Vanguard Group Inc. ($7.86M), Artal Group S.A. ($7.76M), Darwin Global Management Ltd. ($4.81M), and Point72 Asset Management L.P. ($4.54M).Learn more on ELEV's institutional investors.

What percentage of Elevation Oncology stock is owned by institutional investors?

83.70% of Elevation Oncology stock is owned by institutional investors. Learn more on ELEV's institutional investor holdings.

Which institutional investors have been buying Elevation Oncology stock?

Of the 24 institutional investors that purchased Elevation Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($5.99M), Farallon Capital Management LLC ($3.89M), Logos Global Management LP ($2.85M), Darwin Global Management Ltd. ($2.33M), Sphera Funds Management LTD. ($1.65M), Artal Group S.A. ($1.51M), and ExodusPoint Capital Management LP ($1.50M).

How much institutional buying is happening at Elevation Oncology?

Institutional investors have bought a total of 24,244,642 shares in the last 24 months. This purchase volume represents approximately $73.76M in transactions.

Which Elevation Oncology major shareholders have been selling company stock?

Of the 9 institutional investors that sold Elevation Oncology stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Braidwell LP ($2.00M), Point72 Asset Management L.P. ($1.69M), Armistice Capital LLC ($1.65M), Ikarian Capital LLC ($1.02M), Darwin Global Management Ltd. ($416.64K), Farallon Capital Management LLC ($288.25K), and venBio Partners LLC ($218.12K).

How much institutional selling is happening at Elevation Oncology?

Institutional investors have sold a total of 7,426,493 shares in the last 24 months. This volume of shares sold represents approximately $15.45M in transactions.



This page (NASDAQ:ELEV) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners